#BEGIN_DRUGCARD DB03905

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C25H41N8O19P3

# Chemical_IUPAC_Name:
3-[(2-{3-[(2R)-3-[({[({[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido]propanamido}ethyl)carbamoyl]propanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Succinamide-Coa

# HET_ID:
SCO

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C25H41N8O19P3/c1-25(2,20(39)23(40)29-6-5-15(35)28-8-7-27-14(34)3-4-16(36)37)10-49-55(46,47)52-54(44,45)48-9-13-19(51-53(41,42)43)18(38)24(50-13)33-12-32-17-21(26)30-11-31-22(17)33/h11-13,18-20,24,38-39H,3-10H2,1-2H3,(H,27,34)(H,28,35)(H,29,40)(H,36,37)(H,44,45)(H,46,47)(H2,26,30,31)(H2,41,42,43)/t13-,18+,19-,20-,24+/m0/s1

# InChI_Key:
InChIKey=WZEXTLJNSXEEHK-LJEXEIFSSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3905

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
850.5565

# Molecular_Weight_Mono:
850.170080706

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1KGQ

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.98

# Predicted_LogS:
-2.4

# Predicted_Water_Solubility:
3.52e+00 g/l

# Primary_Accession_No:
DB03905

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936824

# PubChem_Substance_ID:
46508917

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02869

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(C)(CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1OP(O)(O)=O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCNC(=O)CCC(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:44 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
dapD

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
8880935	Binder DA, Blanchard JS, Roderick SL: Crystallization and preliminary crystallographic analysis of tetrahydrodipicolinate-N-succinyltransferase. Proteins. 1996 Sep;26(1):115-7.
9012664	Beaman TW, Binder DA, Blanchard JS, Roderick SL: Three-dimensional structure of tetrahydrodipicolinate N-succinyltransferase. Biochemistry. 1997 Jan 21;36(3):489-94.
9671504	Beaman TW, Blanchard JS, Roderick SL: The conformational change and active site structure of tetrahydrodipicolinate N-succinyltransferase. Biochemistry. 1998 Jul 21;37(29):10363-9.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2376

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
29887

# Drug_Target_1_Name:
2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase

# Drug_Target_1_Number_of_Residues:
274

# Drug_Target_1_PDB_ID:
1KGT

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00132	Hexapep

# Drug_Target_1_Protein_Sequence:
>2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MQQLQNVIESAFERRADITPANVDTVTREAVNQVIGLLDSGALRVAEKIDGQWVTHQWLK
KAVLLSFRINDNKVMDGAETRYYDKVPMKFADYDEARFQKEGFRVVPPATVRQGAFIARN
TVLMPSYVNIGAYVDEGTMVDTWATVGSCAQIGKNVHLSGGVGIGGVLEPLQANPTIIED
NCFIGARSEVVEGVIVEEGSVISMGVYLGQSTRIYDRETGEIHYGRVPAGSVVVSGNLPS
KDGSYSLYCAVIVKKVDAKTRGKVGINELLRTID

# Drug_Target_1_Reaction:
succinyl-CoA + (S)-2,3,4,5-tetrahydropyridine-2,6-dicarboxylate + H2O = CoA + N-succinyl-L-2-amino-6-oxoheptanedioate

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Succinyl-CoA + (S)-2,3,4,5-tetrahydropyridine- 2,6-dicarboxylate + H(2)O = CoA + N-succinyl-L-2-amino-6- oxoheptanedioate

# Drug_Target_1_SwissProt_ID:
P56220

# Drug_Target_1_SwissProt_Name:
DAPD_MYCBO

# Drug_Target_1_Synonyms:
EC 2.3.1.117
THP succinyltransferase
Tetrahydrodipicolinate N-succinyltransferase
Tetrahydropicolinate succinylase

# Drug_Target_1_Theoretical_pI:
5.43

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03905
